Therapeutic drug monitoring in a developing country: An overview

British Journal of Clinical Pharmacology

Volumn 48, Issue 5, 1999, Pages 649-654

  Gogtay, N J ^a   Kshirsagar, N A ^a   Dalvi, S S ^a  

^a KEM HOSPITAL   (India)

Author keywords

Developing country; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CIPROFLOXACIN; CYCLOSPORIN; GENERIC DRUG; LITHIUM; MEFLOQUINE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN;

CLINICAL PHARMACOLOGY; DEVELOPING COUNTRY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; ETHNIC DIFFERENCE; HUMAN; INDIA; MANIC DEPRESSIVE PSYCHOSIS; NUTRITIONAL DEFICIENCY; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TEACHING HOSPITAL; TROPICAL DISEASE; TUBERCULOSIS;

EID: 0032735915     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00088.x     Document Type: Review

References (39)

1. 1 Therapeutic drug monitoring and clinical biochemistry. eds Hallworth MJ, Capps NE, ACB Venture Publications, London, pp 1–28, 1993.
2. 2 Eadie MJ. Therapeutic drug monitoring‐anti epileptic drugs. Br J Clin Pharmacol 1998 ; 46, 185 193
3. 3 Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 1998 ; 46, 95 99
4. 4 Kshirsagar NA & Shah PU Management of epilepsy in developing countries. In Recent Advances in Epilepsy, eds Pedley TA, Meldrum BS. 5th edn. London: Churchill Livingstone. 1992: 159–176.
5. 5 Joshi MV, Pohujani SM, Kshirsagar NA, Shah PU, Acharya VN. Simultaneous estimation of phenytoin, phenobarbitone, and carbamazepine. Ind J Pharmacol 1990 ; 22, 177 179
6. 6 Dandekar UP, Chandra RS, Dalvi SS, et al. Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an ayurvedic preparation. J Ethnopharmacol 1992 ; 35, 285 288
7. 7 Gogtay NJ, Rane CT, Dalvi SS, Shah PU, Kshirsagar NA A story of ayurvedic tablets and misled epileptic patients. J Assoc Phys Ind 1999, in press.
8. 8 Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug–herb interactions. Arch Int Med 1998 ; 158, 2200 2211
9. 9 Hamilton JR. Health research in the developing world: a gastroenterological view from Bangladesh. Can J Gastroenterol 1997 ; 11, 94 98
10. 10 Krishnaswamy K. Nutrition and drug metabolism. Ind J Med Res 1978 ; 68 (Suppl) 109 120
11. 11 Felder C & Stewart MJ. Plasma total phenytoin: a possibly misleading test in developing countries. Ther Drug Monit 1999 ; 21, 155 160
12. 12 Joshi MV, Pohujani SM, Mehta BC, Acharya VN, Kshirsagar NA. Effect of iron deficiency anemia and its treatment on single dose phenytoin bioavailability. Eur J Clin Pharmacol 1993 ; 45, 387 388
13. 13 Havlir DV & Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999 ; 340, 367 373
14. 14 Mani KS Collaborative epidemiological study on epilepsy in India. Final report of the Bangalore centre, Department of Neurology, National Institute of mental health and Neurosciences, Bangalore 1987.
15. 15 Shelley RK. Are there ethnic differences in lithium pharmacokinetics and side effects? Int Clin Psychopharmacol 1987 ; 2, 337 342
16. 16 Lee HS. Variability of plasma phenobarbitone concentration in Asian children in Singapore. Ther Drug Monit 1984 ; 6, 182 188
17. 17 Joshi MV, Pohujani SM, Jain SK, Kshirsagar NA, Shah PU, Acharya VN. Phenytoin dose adjustments in Indian population. Neurol Ind 1990 ; 38, 339 342
18. 18 Johnston A & Holt DW. Generic substitution for cyclosporine: What should we be looking for in new formulations? Transplant Proc 1998 ; 30, 1652 1653
19. 19 Qureshi H, Ahmed W, Mehdi I. Locally produced drugs need quality control. J Pak Med Assoc 1998 ; 48, 226 227
20. 20 Cong LD, Yen PT, Nhu TV, Binh LN. Use and quality of anti malarial drugs in the private sector in Vietnam. Bull World Health Org 1998 ; 76, 51 58
21. 21 Anonymous. Generic medicines‐can quality be assured? Drugs Ther Bull 1997 ; 35, 9 11
22. 22 Karande SC, Joshi MV, Kshirsagar NA, Shah PU. An analysis of epileptic patients non responsive to drugs. J Assoc Phys Ind 1992 ; 40, 445 447
23. 23 Singh LM, Mehta S, Vohra RM, Nain CK. Monitoring of drug therapy in epileptic children. Int J Clin Pharmacol Ther Toxicol 1987 ; 25, 251 254
24. 24 Karande SC, Dalvi SS, Kshirsagar NA. Shortcomings in the pharmacotherapy of epileptic children in Bombay, India. J Trop Ped 1995 ; 41, 247 249
25. 25 Peloquin CA. Using therapeutic drug monitoring to dose the anti mycobacterial drugs. Clin Chest Med 1997 ; 18, 79 87
26. 26 Sarma GR, Immaneul C, Kailasam S, Kannapiran M, Nair NG, Radhakrishna S. A modified method for the estimation of acetylisoniazid in urine. Ind J Med Res 1974 ; 62, 945 952
27. 27 Schou M. Forty years of lithium treatment. Arch Gen Psych 1997 ; 54, 9 13
28. 28 Shanming Y. Lithium therapy in China. Brief communication. Acta Psychiat Scand 1981 ; 64, 270 272
29. 29 Abidoun OA. The role of laboratory medicine in psychiatry. East Afr Med J 1991 ; 68, 389 399
30. 30 Lee S. The first lithium clinic in HongKong: a Chinese profile. Aust NZ J Psych 1992 ; 26, 450 453
31. 31 Verghese A, Indrani N, Kuruvilla K, Hill PG. Usefulness of saliva lithium estimation. Br J Psychiat 1977 ; 130, 148 150
32. 32 Khare CB, Sankaranarayanan A, Goel A, Khandelwal SK, Srinivasa Murthy R. Saliva lithium levels for monitoring lithium prophylaxis of manic depressive psychosis. Int J Clin Pharmacol Ther Toxicol 1983 ; 21, 451 453
33. 33 Raj DS, Somiah S, Mani K. Optimal cyclosporine therapy—an Indian experience. J Assoc Phy Ind 1996 ; 44, 34 36
34. 34 Kshirsagar NA, Joshi MV, Shah PU, Dalvi SS. Need for 25 mg tablets of phenytoin. J Assoc Phys Ind 1991 ; 39, 395 396
35. 35 Rane CT, Gogtay NJ, Kadam VS, Powar HS, Dalvi SS, Kshirsagar NA Subtherapeutic levels of phenytoin with standard doses in infants‐need to review dosage schedule. Br J Clin Pharmacol 1999; in press.
36. 36 Gogtay NJ, Garg MR, Bodhe PV, Tilve GH, Kshirsagar NA. Response of vivax malaria to chloroquine in mumbai. J Assoc Phys Ind 1998 ; 46, 843 845
37. 37 Garg MR, Gopinathan N, Bodhe PV, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans Roy Soc Trop Med Hyg 1995 ; 89, 656 657
38. 38 Heaney D & Josemir WAS. Anti epileptic drugs in developing countries. Lancet 1998 ; 351, 1967
39. 39 Shenfield GM. Therapeutic drug monitoring beyond 2000. Br J Clin Pharmacol 1998 ; 46, 93 94